BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21372167)

  • 1. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.
    Hansen EN; Tamboli RA; Isbell JM; Saliba J; Dunn JP; Marks-Shulman PA; Abumrad NN
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G795-802. PubMed ID: 21372167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes.
    Kirwan JP; Axelrod CL; Kullman EL; Malin SK; Dantas WS; Pergola K; Del Rincon JP; Brethauer SA; Kashyap SR; Schauer PR
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4192-e4201. PubMed ID: 33870426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
    Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
    Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
    Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
    Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model.
    Shimizu H; Eldar S; Heneghan HM; Schauer PR; Kirwan JP; Brethauer SA
    Surg Obes Relat Dis; 2014; 10(1):29-35. PubMed ID: 23507630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
    Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
    Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
    Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
    Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early glycemic control and incretin improvement after gastric bypass: the role of oral and gastrostomy route.
    Fernandes G; Santo MA; Crespo AFCB; Biancardi GB; Mota FC; Antonangelo L; de Cleva R
    Surg Obes Relat Dis; 2019 Apr; 15(4):595-601. PubMed ID: 30803884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.